Dr Neal Lindeman speaks to ecancer about non-small cell lung cancer pathology.
Initially, he discusses the latest state of play in diagnostics in EGFR mutated NSCLC.
He then talks about the unmet needs and challenges in this diagnostic setting.
Dr Lindeman mentions some recommended methods for NSCLC identification and diagnostics and explains the current testing methods for EGFR uncommon mutations such as EGFR exon 20 insertions.
He concludes by talking about comprehensive molecular testing for NSCLC with EGFR mutations and what the future looks like for diagnosing this type of lung cancer.
This programme has been supported by an unrestricted educational grant from Takeda